Abstract
This paper is to determine the clinicopathological features and outcome of patients with breast lymphoma seen at a single institution. We have reviewed data on 14 patients with breast lymphoma seen at our institution from 1990 to 2003. All patients were female, with a median age of 47.6 years. Diffuse large B-cell lymphoma (DLBCL) was observed in 9 cases, while follicular, Burkitt's, small lymphocytic, MALT and T-cell lymphoma were observed in 1 case each. 5 patients (35.7%) had stage IE disease, 6 patients (42.9%) had stage IIE disease and 3 patients (21.4%) had stage IV disease. Standard CHOP with or without rituximab was given to all patients with aggressive breast lymphoma (n = 10), while 1 patient with Burkitt's lymphoma received a CHOP-based regimen. The 3-year actuarial survival estimate among all 11 patients with aggressive breast lymphoma was 73%. Among those with localized disease, the estimated 3-year survival was 90%. The actuarial 3-year overall survival (OS) estimate for the entire cohort of 14 patients was 76.9%. Our results indicate that breast lymphoma is not associated with an inferior outcome when treated with standard CHOP-based chemotherapy.
References
Nov 15, 1992·Cancer·H J JeonK Kawabata
Feb 1, 1992·Cancer·R GiardiniF Rilke
Mar 1, 1991·Cancer·P L Cohen, J J Brooks
Dec 15, 1990·Cancer·J C HughS Poppema
Feb 1, 1987·Annals of Surgery·S BrusteinP P Rosen
Mar 1, 1987·The British Journal of Surgery·J M DixonT J Anderson
Jun 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J I BernsteinS A Rosenberg
Jun 1, 1972·Cancer·C Wiseman, K T Liao
Dec 1, 1981·Annals of Surgery·J T SchoutenP P Carbone
Jan 1, 1996·Pathology, Research and Practice·S L AbbondanzoJ Krishnan
Feb 1, 1997·Hematological Oncology·W Y AuR Liang
Jun 20, 2000·Acta Oncologica·I BariştaD Firat
Aug 24, 2000·American Journal of Clinical Oncology·J A LyonsR L Crownover
Jan 30, 2002·Cancer·Susan M DomchekGeorge P Canellos
Apr 22, 2003·Cancer Chemotherapy and Biological Response Modifiers·Armando SantoroLuca Castagna
May 24, 2003·Annals of Hematology·M J J Kuper-HommelG Vreugdenhil
Aug 15, 2003·Leukemia & Lymphoma·D GholamV Ribrag
Nov 1, 1962·Cancer·J J DECOSSEJ H FARROW
Jan 30, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Julie M VoseMary M Horowitz
Apr 23, 2004·Leukemia & Lymphoma·Yeon Hee ParkSeung-Sook Lee
Oct 20, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sayaka YoshidaMasafumi Abe
Citations
Sep 18, 2008·Archives of Gynecology and Obstetrics·Philipp LingohrKarl Peter Rheinwalt
Apr 17, 2008·International Journal of Hematology·Hai-Yi GuoXi-Chun Hu
Jul 3, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MartinelliF Cavalli
Mar 8, 2007·Onkologie·David B GeffenMichael Koretz
Nov 27, 2007·World Journal of Surgical Oncology·Shigeyuki NagataKenzo Wakasugi
Feb 10, 2009·American Journal of Hematology·Patricia ValidireDidier Decaudin
Jul 12, 2011·European Journal of Haematology·Suguru FukuharaKensei Tobinai
Apr 2, 2011·Clinical Lymphoma, Myeloma & Leukemia·Shu ZhaoXiao-Chuan Wang
May 24, 2014·International Journal of Clinical Practice·Y LiN Tong
Nov 10, 2015·Indian Journal of Pathology & Microbiology·Jianguo WeiCheng Wang